Array Biopharma
AcquiredArray Biopharma was founded in 1998, is headquartered in Boulder, United States, and lists 51–200 employees.
- Headquarters
- Boulder, Colorado
- Employees
- 51–200
- Founded
- 1998
- Business Model
- B2B
About
Array BioPharma Inc. (NASDAQ: ARRY) was a biopharmaceutical company focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients with cancer, with sites in Boulder, Colorado; Cambridge, Massachusetts; and Morrisville, North Carolina. Its pipeline included binimetinib, encorafenib, selumetinib (with AstraZeneca), and larotrectinib (with Loxo Oncology), among other partnered and Array-owned programs. Pfizer acquired Array BioPharma in 2019 for roughly $11.4 billion for its cancer drug portfolio.
Summary
Array Biopharma is a Biotech company based in Boulder, United States, founded in 1998. It lists 51–200 employees.
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
China's leading blood products manufacturer
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/array-biopharma"><img src="https://indexed.vc/api/badge/company/array-biopharma" alt="Array Biopharma on Indexed.vc" width="260" height="76" /></a>